bicalutamide and trelstar

bicalutamide has been researched along with trelstar in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (33.33)	29.6817
2010's	6 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bossi, P; Cantù, G; Licitra, L; Locati, LD; Marchianò, AV; Quattrone, P	1
Di Silverio, F; Sciarra, A	1
Akdogan, B; Akyol, F; Karabulut, E; Onal, C; Ozen, H; Ozyigit, G; Selek, U	1
López, MA; Morote, J; Placer, J; Planas, J; Raventós, C; Ropero, J; Salvador, C	1
Bossi, P; Civelli, E; Cortelazzi, B; Imbimbo, M; Licitra, L; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P; Rinaldi, G	1
Antes, G; Dahm, P; Grobe, HR; Kunath, F; Meerpohl, JJ; Motschall, E; Rücker, G; Wullich, B	1
Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S	1
Bergamini, C; Bossi, P; Civelli, E; Cortelazzi, B; Dagrada, G; Fallai, C; Licitra, L; Lo Vullo, S; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P	1
Abraham, C; Banu, E; Beuzeboc, P; Bozec, L; Caty, A; Culine, S; Delva, R; Deplanque, G; Elaidi, R; Ferrero, JM; Gomez, P; Gravis, G; Hardy-Bessard, AC; Houede, N; Krakowski, I; Lagrange, JL; Latorzeff, I; Linassier, C; Miglianico, L; Mouret, L; Muracciole, X; Oudard, S; Priou, F; Ravaud, A; Rolland, F; Sevin, E; Voog, E; Zylberait, D	1

Reviews

1 review(s) available for bicalutamide and trelstar

Article	Year
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. The Cochrane database of systematic reviews, 2014, Jun-30, Issue:6 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Disease Progression; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Medication Adherence; Nitriles; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds; Triptorelin Pamoate	2014

Article

Year

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.

The Cochrane database of systematic reviews, 2014, Jun-30, Issue:6

Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Disease Progression; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Medication Adherence; Nitriles; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds; Triptorelin Pamoate

2014

Trials

2 trial(s) available for bicalutamide and trelstar

Article	Year
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma. Urology, 2004, Volume: 63, Issue:3 Topics: Adenocarcinoma; Aged; Androgens; Anilides; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Cell Differentiation; Chromogranin A; Chromogranins; Disease Progression; Gonadotropin-Releasing Hormone; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neurosecretory Systems; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds; Triptorelin Pamoate	2004
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial. JAMA oncology, 2019, May-01, Volume: 5, Issue:5 Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitriles; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Risk; Tosyl Compounds; Triptorelin Pamoate	2019

Article

Year

Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma.

Urology, 2004, Volume: 63, Issue:3

Topics: Adenocarcinoma; Aged; Androgens; Anilides; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Cell Differentiation; Chromogranin A; Chromogranins; Disease Progression; Gonadotropin-Releasing Hormone; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neurosecretory Systems; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds; Triptorelin Pamoate

2004

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

JAMA oncology, 2019, May-01, Volume: 5, Issue:5

Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitriles; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Risk; Tosyl Compounds; Triptorelin Pamoate

2019

Other Studies

6 other study(ies) available for bicalutamide and trelstar

Article	Year
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Parotid Gland; Parotid Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; Risk Assessment; Skin Ulcer; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate	2003
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer. Journal of the National Medical Association, 2006, Volume: 98, Issue:7 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Disease Progression; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Tosyl Compounds; Triptorelin Pamoate	2006
[Impact of androgen deprivation on the lipid profile and atherogenic risk in prostate cancer patients]. Actas urologicas espanolas, 2012, Volume: 36, Issue:4 Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Atherosclerosis; Biopsy; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Gonadotropin-Releasing Hormone; Humans; Lipoproteins; Male; Nitriles; Prostate; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Risk; Tosyl Compounds; Triglycerides; Triptorelin Pamoate	2012
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy. Cancer biology & therapy, 2014, Jun-01, Volume: 15, Issue:6 Topics: Adenocarcinoma; Adult; Androgen Antagonists; Androstenes; Androstenols; Anilides; Antineoplastic Agents, Hormonal; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate	2014
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort. World journal of urology, 2015, Volume: 33, Issue:6 Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate	2015
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers. Head & neck, 2016, Volume: 38, Issue:5 Topics: Adult; Aged; Androgen Antagonists; Anilides; Biomarkers; DNA Mutational Analysis; ErbB Receptors; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Receptors, Androgen; Retrospective Studies; Salivary Gland Neoplasms; Survival Analysis; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate	2016